Marketed without an approved NDA/ANDA: Samantha Lynn Inc. is recalling Reumofan Plus Tablets because it contains undeclared drug ingredients making it an unapproved drug.
Marketed without an approved NDA/ANDA: Samantha Lynn Inc. is recalling Reumofan Plus Tablets because it contains undeclared drug ingredients making it an unapproved drug.
We break every recall down into plain English — this one’s still on our list. Until our write-up is ready, the official FDA hazard and remedy below have the full, accurate details.
We’ve drafted a message you can send Samantha Lynn, Inc to request your refund or repair — edit it as you like.
Subject: Recall D-063-2013 — Samantha Lynn, Inc Samantha Lynn, Inc recalls Reumofan Plus Tablets, 30-count bottle per Box, (remai Hello, I own a Samantha Lynn, Inc recalls Reumofan Plus Tablets, 30-count bottle per Box, (remaining label information in Spanish) that is covered by recall D-063-2013 from Samantha Lynn, Inc. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
